Poster can be found in location 96.

Background: Person-centred care (PCC) interventions have been associated with economic benefits. However, the paradigm shift towards PCC places greater emphasis on healthcare systems to recognise key social determinants of health (SDoH) to ensure equitable healthcare, whilst acknowledging the importance of the demographic distributional aspects of the global population. Objective: To explore to what extent the current evidence about the costs and associated health outcomes of PCC reflects sub-groups of the population by the social determinants of health. Method: A systematic review was conducted with retrieved literature from PubMed, Scopus, CINAHL, and grey literature using free-text and MeSH terms related to PCC, costs, and benefits. Papers that defined PCC as a partnership were included. Study selection and data extraction according to a standardised extraction sheet was conducted by two independent reviewers. A narrative synthesis was used for demographic characteristics and exclusion/inclusion criteria to understand how SDoH were taken into consideration, using deductive analysis to the rainbow model by Dahlgren and Whitehead. Results: A total of 2,766 papers were initially identified, of which, only 32 met the inclusion criteria. All studies included populations from developed countries and were predominantly randomised controlled trials or quasi-experimental designs. Of the 32 studies, 28 reported their inclusion/exclusion criteria. Disease and related symptoms were reported in all the studies when enrolling patients. Disabilities, language, ethnicity, and life expectancy were defined in the exclusion criteria of 19 studies. Age and gender were the most frequent SDoH amongst other reported determinants: ethnicity, income, and education. Only 2 studies performed sub-group analyses. Conclusion: The findings indicate that the evidence on the cost-effectiveness of PCC does not account for many of the SDoH. There is a risk that the underrepresentation of vulnerable population groups and their specific needs could lead to imbalances in evaluating and implementing PCC interventions. Prospero Registration #: CRD42022313047.